CD46-utilizing Adenoviruses Inhibit C/EBPbeta-dependent Expression of Proinflammatory Cytokines

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2005 Aug 17

PMID 16103178

Citations 15

Authors

Milena Iacobelli-Martinez

Ronald R Nepomuceno

Jodi Connolly

Glen R Nemerow

Affiliations

Soon will be listed here.

Abstract

The majority of adenovirus serotypes utilize the coxsackievirus-adenovirus receptor (CAR) for virus-host cell attachment, but subgroup B and subgroup D (adenovirus type 37 [Ad37]) viruses recognize CD46. CD46 is a ubiquitously expressed receptor that serves as a cofactor for the inactivation of the complement components C3b and C4b, and it also serves as a receptor for diverse microbial pathogens. A reported consequence of CD46 engagement is a reduced capability of human immune cells to express interleukin-12 (IL-12), a cytokine involved in both the innate and adaptive immune responses. Studies were thus undertaken to determine whether CD46-utilizing Ads alter the expression of proinflammatory cytokines. Subgroup B (Ad16 and -35) and Ad37, but not Ad2 or -5, significantly reduced IL-12 production by human peripheral blood mononuclear cells stimulated with gamma interferon (IFN-gamma) and lipopolysaccharide. IL-12 mRNA (p35 and p40 subunits) levels as well as other cytokine mRNA levels (IL-1alpha and -beta, IL-1Ra, and IL-6) were decreased upon interaction with CD46-utilizing Ads. Analysis of transcription factor activity required for cytokine expression indicated that CD46-utilizing Ads preferentially inhibited IFN-gamma-induced C/EBPbeta protein expression, consequently reducing its ability to form DNA complexes. Interference with IFN-gamma signaling events by CD46-utilizing Ads, but not CAR-utilizing Ads, reveals a potentially critical difference in the host immune response against distinct Ad vectors, a situation that has implications for gene delivery and vaccine development.

Citing Articles

Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.

Dai Z, Si Y, Xiong S, Li Y, Ye J, Gao Q Cancer Gene Ther. 2025; .

PMID: 40057574 DOI: 10.1038/s41417-025-00884-x.

The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.

Wallace R, Bliss C, Parker A Viruses. 2024; 16(6).

PMID: 38932265 PMC: 11209478. DOI: 10.3390/v16060973.

The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal.

Nestic D, Bozinovic K, Pehar I, Wallace R, Parker A, Majhen D Pharmaceutics. 2021; 13(10).

PMID: 34683878 PMC: 8540258. DOI: 10.3390/pharmaceutics13101585.

Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties.

Daussy C, Pied N, Wodrich H Viruses. 2021; 13(7).

PMID: 34202573 PMC: 8310329. DOI: 10.3390/v13071221.

Adenovirus and the Cornea: More Than Meets the Eye.

Rajaiya J, Saha A, Ismail A, Zhou X, Su T, Chodosh J Viruses. 2021; 13(2).

PMID: 33668417 PMC: 7917768. DOI: 10.3390/v13020293.

References

Wang G, Liszewski M, Chan A, Atkinson J . Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J Immunol. 2000; 164(4):1839-46. DOI: 10.4049/jimmunol.164.4.1839. View

Roy S, Wachira S, Weihua X, Hu J, Kalvakolanu D . CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J Biol Chem. 2000; 275(17):12626-32. DOI: 10.1074/jbc.275.17.12626. View

Li E, Stupack D, Brown S, Klemke R, Schlaepfer D, Nemerow G . Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem. 2000; 275(19):14729-35. DOI: 10.1074/jbc.275.19.14729. View

Hu J, Roy S, Shapiro P, Rodig S, Reddy S, Platanias L . ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem. 2000; 276(1):287-97. DOI: 10.1074/jbc.M004885200. View

Peng Y, Elkon K . Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation. J Virol. 2001; 75(10):4540-50. PMC: 114207. DOI: 10.1128/JVI.75.10.4540-4550.2001. View

Zhang Y, Chirmule N, Gao G, Qian R, Croyle M, Joshi B . Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther. 2001; 3(5 Pt 1):697-707. DOI: 10.1006/mthe.2001.0329. View

Schnell M, Zhang Y, Tazelaar J, Gao G, Yu Q, Qian R . Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther. 2001; 3(5 Pt 1):708-22. DOI: 10.1006/mthe.2001.0330. View

Atabani S, Byrnes A, Jaye A, Kidd I, Magnusen A, Whittle H . Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis. 2001; 184(1):1-9. DOI: 10.1086/321009. View

Becker C, Wirtz S, Ma X, Blessing M, Galle P, Neurath M . Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2). J Immunol. 2001; 167(5):2608-18. DOI: 10.4049/jimmunol.167.5.2608. View

10.

Zaffran Y, Destaing O, Roux A, Ory S, Nheu T, Jurdic P . CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol. 2001; 167(12):6780-5. DOI: 10.4049/jimmunol.167.12.6780. View

11.

Higginbotham J, Seth P, Blaese R, Jay Ramsey W . The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum Gene Ther. 2002; 13(1):129-41. DOI: 10.1089/10430340152712683. View

12.

Tibbles L, Spurrell J, Bowen G, Liu Q, Lam M, Zaiss A . Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol. 2002; 76(4):1559-68. PMC: 135878. DOI: 10.1128/jvi.76.4.1559-1568.2002. View

13.

Bowen G, Borgland S, Lam M, Libermann T, Wong N, Muruve D . Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther. 2002; 13(3):367-79. DOI: 10.1089/10430340252792503. View

14.

Lee S, Bonnah R, Higashi D, Atkinson J, Milgram S, So M . CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J Cell Biol. 2002; 156(6):951-7. PMC: 2173477. DOI: 10.1083/jcb.200109005. View

15.

La E, Rundhaug J, Pavone A, Fischer S . Regulation of transcription of the intracellular interleukin-1 receptor antagonist gene by AP-1 in mouse carcinoma cells. Mol Carcinog. 2002; 33(4):237-43. DOI: 10.1002/mc.10042. View

16.

Huang S, Endo R, Nemerow G . Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol. 1995; 69(4):2257-63. PMC: 188895. DOI: 10.1128/JVI.69.4.2257-2263.1995. View

17.

Ma X, Chow J, Gri G, Carra G, Gerosa F, Wolf S . The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996; 183(1):147-57. PMC: 2192398. DOI: 10.1084/jem.183.1.147. View

18.

Hambleton J, Weinstein S, Lem L, DeFranco A . Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A. 1996; 93(7):2774-8. PMC: 39708. DOI: 10.1073/pnas.93.7.2774. View

19.

Karp C, Wysocka M, Wahl L, Ahearn J, Cuomo P, Sherry B . Mechanism of suppression of cell-mediated immunity by measles virus. Science. 1996; 273(5272):228-31. DOI: 10.1126/science.273.5272.228. View

20.

Bergelson J, Cunningham J, Droguett G, Krithivas A, Hong J, Horwitz M . Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997; 275(5304):1320-3. DOI: 10.1126/science.275.5304.1320. View